GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Hotgen Biotech Co Ltd (SHSE:688068) » Definitions » Deferred Policy Acquisition Costs

Beijing Hotgen Biotech Co (SHSE:688068) Deferred Policy Acquisition Costs


View and export this data going back to 2019. Start your Free Trial

What is Beijing Hotgen Biotech Co Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Beijing Hotgen Biotech Co (SHSE:688068) Business Description

Traded in Other Exchanges
N/A
Address
No. 9 Tianfu Street, 9th Building, Bio-Medical Base, Daxing District, Beijing, CHN, 102600
Beijing Hotgen Biotech Co Ltd is engaged in the development and manufacturing of innovative in-vitro diagnostic, point-of-care-testing and biodefense products.
Executives
Zhou Xin Director